GSK has made its first major acquisition under new chief executive Luke Miels, buying US biotech…
Continue ReadingTag: Rapt
GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal
GSK’s presence in immunology and inflammation is heavily oriented around respiratory drugs, but the company has…
Continue Reading